Dublin, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The "Synthetic Biology Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering.
Synthetic Biology Market value will surpass US$22.2 billion in 2024
This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Diverse Application of Synthetic Biology will trigger the market growth
Some of the major forces propelling the synthetic biology market include advancements in genetic engineering, and rising investment and funding. Furthermore, breakthroughs in CRISPR-Cas9 and other gene-editing technologies have revolutionized the ability to precisely manipulate genetic material, accelerating synthetic biology research and applications.
On the other hand, The collaborative efforts among academic institutions, research organizations, and industry players are fostering innovation and accelerating the commercialization of synthetic biology technologies. In addition, increased public awareness and acceptance of synthetic biology products, particularly in food and healthcare, are driving market growth. Consumers are becoming more open to the benefits of synthetic biology-derived products.
Lack of Skilled professionals Challenges to Hamper Industry Growth
The synthetic biology market faces significant challenges due to a shortage of skilled professionals, which hampers its growth and development. There is a notable gap between the demand for skilled synthetic biologists and the available talent pool. This gap makes it difficult for companies and research institutions to find qualified personnel to advance their projects.
The lack of skilled professionals in synthetic biology slows down research and development efforts. Without sufficient expertise, the pace of innovation is hindered, delaying the introduction of new technologies and applications.
Key Questions Answered
- How is the Synthetic Biology Market evolving?
- What is driving and restraining the Synthetic Biology Market?
- How will each synthetic biology submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
- How will the market shares for each Synthetic Biology submarket develop from 2024 to 2034?
- What will be the main driver for the overall market from 2024 to 2034?
- Will leading Synthetic Biology Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
- Who are the leading players and what are their prospects over the forecast period?
- What are the Synthetic Biology projects for these leading companies?
- How will the industry evolve during the period between 2024 and 2034? What are the implications of Synthetic Biology projects taking place now and over the next 10 years?
- Where is the Synthetic Biology Market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
Synthetic Biology Market Dynamics
Market Driving Factors
- Diverse Application of Synthetic Biology
- Increasing R&D Investments in Drug Discovery and Development
- Increasing Biofuel Demand
Market Restraining Factors
- Lack Of Skilled Professionals And Research Support In developing Countries
- High Treatment Cost of Oligonucleotide
Market Opportunities
- Growth in Research on Synthetic Drugs and Vaccines
- Increasing Demand for Fuel Alternatives
Emerging Technologies
- CRISPR-Cas9 and Gene Editing
- Application of AI in Synthetic biology
Regulatory Framework
COVID-19 Impact Analysis
Porter's Five Forces Analysis
PEST Analysis
Company Profiles
- Agilent Technologies Inc.
- Algenol Biofuels Inc.
- Amyris Inc.
- Danaher Corporation
- Genscript Biotech Corporation
- Ginkgo Bioworks
- Intrexon Corp. (Precigen Inc.)
- Thermo Fisher Scientific Inc.
- Merck KGaA
- New England Biolabs
- Synthetic Genomics (Viridos)
- Twist Bioscience Corp.
- Xcelris Labs Ltd.
- 3D Systems
- Codexis
- GE Healthcare
Segments Covered in the Report
Product Type Outlook
- Oligonucleotides & Synthetic DNA
- Enzymes
- Cloning Technology Kits
- Synthetic Cells
- Chassis Organisms
- Xeno-Nucleic Acids
Technology
- Gene Synthesis
- Genome Engineering
- Sequencing
- Bioinformatics
- Cloning
- Site-Directed Mutagenesis
- Measurement & Modeling
- Microfluidics
- Nanotechnology
Application
- Medical & Pharmaceutical Applications
- Industrial Applications
- Food & Agriculture
- Environmental Applications
End-user
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutes
- Others
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Spain
- Italy
- Russia
- Belgium
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Malaysia
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
MEA
- Turkey
- Saudi Arabia
- South Africa
- UAE
- Egypt
- Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/pxmst9
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
